Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic porphyrias.

Y V Scarlett1, D A Brenner, J R Bloomer

  • 1Division of Digestive Diseases and Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Clinics in Liver Disease
|November 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Signal transduction during liver regeneration.

Journal of gastroenterology and hepatology·2017
Same author

Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study.

Alimentary pharmacology & therapeutics·2016
Same author

Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease.

Alimentary pharmacology & therapeutics·2015
Same author

Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction.

CPT: pharmacometrics & systems pharmacology·2014
Same author

Evidence for a common progenitor of epithelial and mesenchymal components of the liver.

Cell death and differentiation·2013
Same author

Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.

Alimentary pharmacology & therapeutics·2013
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Porphyrias are metabolic disorders caused by abnormal heme biosynthesis due to enzyme defects. This article details hepatic porphyrias, focusing on enzymes, clinical features, and management.

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Genetics

Background:

  • Porphyrias are a group of metabolic diseases.
  • Characterized by abnormal heme biosynthesis.
  • Enzyme defects in the heme pathway cause excessive porphyrin accumulation.

Purpose of the Study:

  • Describe enzymes in the heme biosynthetic pathway.
  • Outline clinical features of hepatic porphyrias.
  • Discuss management strategies for these disorders.

Main Methods:

  • Review of literature on heme biosynthesis.
  • Analysis of enzyme functions in the pathway.
  • Compilation of clinical data for hepatic porphyrias.

Main Results:

Related Experiment Videos

  • Detailed description of eight enzymes in the heme biosynthetic pathway.
  • Identification of specific enzyme defects leading to different porphyrias.
  • Summary of characteristic clinical manifestations.

Conclusions:

  • Hepatic porphyrias result from specific enzyme deficiencies in heme synthesis.
  • Understanding these enzymes is crucial for diagnosis and management.
  • Effective management strategies can improve patient outcomes.